{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[9,2,9,3],[10,2,10,3],[12,2,12,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910568256403321"]
[null,null,"Titolo",null,"CPAP adherence : factors and perspectives / / Colin M. Shapiro, Meenakshi Gupta, and Dora Zalai, editors"]
[null,null,"Pubbl/distr/stampa",null,"Cham, Switzerland : , : Springer International Publishing, , [2022]"]
[{"$nulls":4},"©2022"]
[null,null,"ISBN",null,"3-030-93146-3"]
[null,null,"Descrizione fisica",null,"1 online resource (388 pages)"]
[null,null,"Disciplina",null,"615.5"]
[null,null,"Soggetti",null,"Patient compliance"]
[{"$nulls":4},"Artificial respiration"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Intro -- Foreword -- Reference -- Preface -- References -- Contents -- Contributors -- Part I: Approaches to Promoting PAP Adherence -- 1: When to Treat with CPAP and How to Define Success -- 1.1  Historical Perspective and Description of Methods of Positive Airway Pressure Delivery -- 1.1.1  Evolution of Positive Airway Pressure -- 1.1.2  Description of Various PAP Modes -- 1.1.2.1  Continuous and Auto-Adjusting Positive Airway Pressure (CPAP and APAP) -- 1.1.2.2  Bi-Level PAP (BPAP) and Auto-Adjusting BPAP -- 1.1.2.3  Adaptive Servo Ventilation (ASV) -- 1.2  When to Treat with CPAP -- 1.2.1  Obstructive Sleep Apnea (OSA) -- 1.2.1.1  Treatment of Symptomatic OSA -- Excessive Daytime Sleepiness -- Sleep Quality -- Snoring/Apneas -- Cognitive Issues -- Mood -- Overall Quality of Life (QoL) -- 1.2.1.2  Prevent or Treat Comorbid Medical Problems -- Cardiovascular Disease (CVD) -- Coronary Artery Disease -- Atrial Fibrillation (AF) and Other Arrhythmias -- Stroke -- Hypertension -- Congestive Heart Failure (CHF) -- Type 2 Diabetes Mellitus -- Other Medical Conditions -- Chronic Kidney Disease (CKD) -- Non-alcoholic Fatty Liver Disease -- Gastroesophageal Reflux Disease (GERD) -- Chronic Headaches -- Pulmonary Hypertension -- 1.2.1.3  OSA Severity and Decision to Use CPAP -- 1.2.2  Central Sleep Apnea -- 1.2.2.1  Closed Airway Central Sleep Apnea -- 1.2.2.2  Treatment-Emergent Central Sleep Apnea -- 1.3  Defining Treatment Success -- 1.3.1  Self-Report -- 1.3.2  Questionnaires -- 1.3.2.1  Quality of Life Instruments -- 1.3.2.2  Assessment of Daytime Sleepiness -- 1.3.3  Objective Assessment of CPAP Adherence -- 1.3.3.1  Interpretation of PAP "]
[{"$nulls":4},"Compliance Reports -- 1.3.3.2  What Is Treatment Success? -- 1.4  Summary -- References -- 2: Interventions to Improve CPAP Adherence -- 2.1  Material and Methods -- 2.1.1  Study Selection."]
[{"$nulls":4},"2.1.2  Data Extraction -- 2.1.3  Data Synthesis -- 2.2  Results -- 2.2.1  Risk of Bias in the Included Studies -- 2.2.2  Study Size and Study Characteristics -- 2.2.3  Study Design -- 2.2.4  Country of Study Origin and Setting -- 2.2.5  Diagnoses -- 2.2.6  Intervention Strategies -- 2.3  Patient-Directed Interventions -- 2.3.1  Education -- 2.3.2  Interventions Directed toward Patient Behavior and Affective State -- 2.3.3  Surgical Modification of Patients' Upper Airway and Myofunctional Therapy -- 2.4  Technology-Targeted Interventions -- 2.4.1  Auto-Titrating or Pressure Relief Machines -- 2.4.2  Types of Masks -- 2.4.3  Humidifier -- 2.5  Duration of Follow-Up Period -- 2.6  Adherence Measures and Outcomes -- 2.7  Intervention Benefits Toward Health and Functional Outcomes -- 2.8  Discussion -- 2.9  Future Direction -- References -- 3: Patient Adherence to CPAP: A Practical Interdisciplinary Model -- 3.1  Introduction -- 3.2  Style of Interaction -- 3.3  A Second Level of Perspective -- 3.4  Conclusion -- References -- 4: Soft Styles of Motivating Patients to Adopt CPAP -- 4.1  Demographic Variables -- 4.2  OSA Disease Issues -- 4.3  Nonmechanical or \"Soft\" Comorbidities -- 4.3.1  Major Mental Illnesses -- 4.3.2  Insomnia and Other Subjective Sleep Issues -- 4.3.3  Psychological Variables -- 4.3.4  Spousal and Partner Support -- 4.3.5  Adherence Measurements -- 4.4  Is CPAP Right for This Patient or Is This the Right Time? -- 4.5  Delivery of Service-Diagnosis -- 4.6  Interventions -- 4.6.1  Addition of a Hypnotic to Improve Adherence -- 4.6.2  Educational, Supportive, and Behavioral Interventions for CPAP Adherence -- 4.6.3  CPAP Adherence in Children and Adolescents -- 4.7  Approaches Using Remote Health Information Technologies (RHIT) (Telehealth, Telemonitoring, eHealth) -- 4.8  Conclusion -- References."]
[{"$nulls":4},"5: The Role of Education and Support in CPAP Adherence -- 5.1  Why Is CPAP Adherence Important? -- 5.2  Baseline Factors Affecting Adherence -- 5.3  The Role of Education During CPAP Set-up -- 5.4  Specific Behavioural Interventions -- 5.5  The CPAP Interface and Adherence -- 5.6  The Pattern of CPAP Usage Is Established Early -- 5.7  Early Follow-up -- 5.8  The Role of Telemonitoring -- 5.9  Support and Troubleshooting -- 5.10  Summary -- References -- 6: Role of the Behavioral Sleep Specialist Psychologist in Promoting CPAP Adherence -- 6.1  When the Patient Is Ambivalent About CPAP Use: The Importance of Client-Clinician Communication -- 6.1.1  Background -- 6.1.2  What Happened to Mark? -- 6.1.3  Research Evidence -- 6.2  When the Patient Has Insomnia: Treating Comorbid Chronic Insomnia to Help with CPAP Use -- 6.2.1  Background -- 6.2.2  What Happened to Steve? -- 6.2.3  Research Evidence -- 6.3  When the Patient Has Anxiety that Impedes CPAP Use -- 6.3.1  Background -- 6.3.2  What Happened to Catherine? -- 6.3.3  Research Evidence -- 6.4  When the Patient Has Mental Health Problems -- 6.5  Chapter Summary -- References -- 7: Role of the Physician in CPAP Adherence and CPAP Trials -- 7.1  Introduction -- 7.2  Threshold for CPAP Trials -- 7.3  Suboptimal Compliance Versus Lack of Effectiveness of CPAP -- 7.4  Strategies to Manage a Poor Response to CPAP -- 7.4.1  Poor Adherence -- 7.4.1.1  Technical Factors -- 7.4.1.2  Poor Adherence after Technical Factors Have Been Addressed -- 7.4.2  Lack of Effectiveness of CPAP -- 7.4.2.1  Failure to Control OSA -- 7.4.2.2  Mild OSA -- 7.4.2.3  Patients with Non-Classical OSA Symptoms -- 7.4.2.4  Persistent Sleepiness Despite Control of OSA -- Coexistent Sleep Disorders -- Periodic Leg Movements -- Comorbid OSA and Insomnia (COMISA) -- Comorbidities and Medications -- Idiopathic "]
[{"$nulls":4},"Persistent Sleepiness."]
[{"$nulls":4},"7.5  Conclusion -- References -- 8: PAP Therapy for Sleep Breathing Disorders: Good Policies and Practices -- 8.1  Guiding Patients to Improve Adherence -- 8.2  What Practice Guidelines Suggest -- 8.3  What Is Adherence? -- 8.4  Strategies to Augment PAP Compliance -- 8.4.1  Match Patient to the Optimal Interface -- 8.4.2  Patient Education and Serial Follow-Up -- 8.4.3  Frequent Telephone Follow-Up -- 8.4.4  Matching Patient and Treatment -- 8.4.5  Familiarizing Patients with Their Medical Equipment Provider -- 8.4.6  Scheduling In-Lab PAP Titration -- 8.4.7  Modifying the Definition of PAP Adherence -- 8.4.8  Identify the Group of Patients with High Risk of Non-Compliance -- 8.4.9  Ruling Out Claustrophobia -- 8.4.10  Cognitive Therapy -- 8.4.11  Social Support -- 8.4.12  Convenient Referral Stream to Ear, Nose, and Throat (ENT) Specialists -- 8.4.13  Sedative-Hypnotic Use Early on -- 8.4.14  Using Smartphone-Based Technologies to Improve Compliance -- 8.4.15  The Importance of Patient Feedback -- 8.5  Conclusion -- References -- Part II: Factors Influencing PAP Adherence -- 9: Socioeconomic Differences in CPAP Adherence -- 9.1  Introduction -- 9.2  The Evidence for Differences in CPAP Adherence by SES -- 9.3  Possible Explanatory Factors for Differences by SES -- 9.4  Summary -- References -- 10: The Impact of Partner and Family Support in PAP Therapy -- 10.1  Introduction -- 10.2  Impact of Untreated OSA on Partners and Family Members -- 10.3  Impact of PAP Treatment on Partners' Sleep and Daytime Functioning -- 10.4  Impact of Partner and Family Involvement on PAP Adherence -- 10.4.1  Presence of Spouse or Live-in Partner -- 10.4.2  Family Involvement -- 10.4.3  Partner Involvement -- 10.5  Partner and Family Involvement in PAP Adherence Interventions -- 10.6  Summary -- 10.7  Conclusion -- References."]
[{"$nulls":4},"11: Personality and Mental Health as Determinants of CPAP Use -- 11.1  Introduction -- 11.2  Diagnosis of Personality Disorders -- 11.3  Personality Disorders and Adherence to CPAP and Obstructive Sleep Apnea Therapies -- 11.4  Increasing Adherence to CPAP and Other Treatments -- 11.5  Conclusion -- References -- 12: Costs of Treatment Non-adherence in Obstructive Sleep Apnoea -- 12.1  Prevalence of OSA -- 12.2  Burden of Untreated OSA -- 12.2.1  Clinical Burden of Untreated OSA -- 12.2.2  Societal and Economic Burden of Untreated OSA -- 12.2.3  Patient Factors in Socioeconomic Burden of OSA -- 12.2.4  Geographic Factors in Socioeconomic Burden of OSA -- 12.2.5  Motor Vehicle Accidents (MVA) in Socioeconomic Burden of OSA -- 12.2.6  Workplace Accidents and OSA in Socioeconomic Burden of OSA -- 12.2.7  Work Productivity in Socioeconomic Burden of OSA -- 12.3  Benefits of OSA Treatment -- 12.3.1  Societal and Health Economic Benefits of OSA Treatment -- 12.3.2  Benefits of CPAP in Mild OSA -- 12.4  Costs of OSA Diagnosis and Treatment -- 12.5  Cost-Effectiveness and Socioeconomic Impact of OSA Treatment -- 12.5.1  Cost-Effectiveness and Socioeconomic Impact of CPAP Treatment -- 12.5.2  Cost-Effectiveness of CPAP Treatment in Mild OSA -- 12.5.3  Cost-Effectiveness of OAT and Surgery -- 12.6  CPAP Non-adherence -- 12.6.1  Prevalence of Non-adherence to CPAP -- 12.6.2  Clinical Factors Associated with Non-adherence to CPAP -- 12.6.3  Socioeconomic Factors Associated with Non-adherence to CPAP -- 12.7  Costs of OSA Treatment Non-adherence -- 12.7.1  Clinical Costs of OSA Treatment Non-adherence -- 12.7.2  Socioeconomic Costs of Non-adherence to OSA Treatment -- References -- 13: Obstructive Sleep Apnea Phenotypes and Positive Airway Therapy Adherence -- 13.1  Factors Affecting CPAP Adherence -- 13.2  Phenotypes of Sleep Apnea in Regard to Adherence."]
[{"$nulls":4},"13.3  Phenotyping Approaches."]